Breaking News Instant updates and real-time market news.

SRPT

Sarepta

$34.95

-0.3 (-0.85%)

08:42
07/18/17
07/18
08:42
07/18/17
08:42

Sarepta, BioMarin execute global settlement, license agreement

Sarepta Therapeutics (SRPT) and BioMarin Pharmaceutical (BMRN) announced that Sarepta and BioMarin executed a license agreement that provides Sarepta Therapeutics with global exclusive rights to BioMarin's DMD patent estate for EXONDYS 51 and all future exon-skipping products. BioMarin retains the right to convert the license to a co-exclusive right in the event it decides to proceed with an exon-skipping therapy for DMD. In addition, Sarepta and BioMarin executed a settlement agreement, resolving the ongoing worldwide patent proceedings related to the use of EXONDYS 51 and all future exon-skipping products for the treatment of DMD. The effectiveness of the agreements is subject to closing conditions including execution of necessary approvals by Academisch Ziekenhuis Leiden by July 24, 2017. Under the terms of the license and settlement agreements, Sarepta will make a one-time payment of $35 million to BioMarin and certain additional regulatory and commercial milestone payments for exons 51, 45, 53 and possibly on future exon-skipping products.

  • 19

    Jul

SRPT Sarepta
$34.95

-0.3 (-0.85%)

07/12/17
BARD
07/12/17
NO CHANGE
Target $102
BARD
Outperform
Sarepta survey points to solid Q2 growth, says Baird
Baird analyst Brian Skorney surveyed 30 neurologists and results suggest Q2 could see an increase in new prescriptions as well as new patients on Exondys 51. He believes consistent growth and continued execution should ease investor concerns heading into the second half of 2017. Skorney reiterated his Outperform rating and $102 price target on Sarepta shares.
06/29/17
FBCO
06/29/17
NO CHANGE
Target $64
FBCO
Outperform
Sarepta selection of veteran CEO a positive, says Credit Suisse
Credit Suisse analyst Alethia Young said Sarepta's (SRPT) selection of Doug Ingram, an established industry veteran and a former president at Allergan (AGN), as its new CEO is a positive, noting that Ingram has experience both in the CNS space and at running a large scale pharmaceutical company. Young, who would guess that the hiring will be viewed positively and sees Sarepta shares trading up following the news, keeps an Outperform rating and $64 price target on the stock.
06/08/17
OPCO
06/08/17
NO CHANGE
Target $76
OPCO
Outperform
Sarepta would be 'bargain' if acquired, says Oppenheimer
Sarepta Therapeutics' current valuation is not reflecting the company's FY17 guidance for Exondys 51 and long-term data on slowing progression of Duchenne muscular dystrophy, Oppenheimer analyst Hartaj Singh tells investors in a research note. If an acquirer were to target Sarepta, recent biotech deals imply that the company "would be a bargain" just on Exondys 51 worldwide sales potential of $750M and without other exon mutations, the analyst contends. Singh notes the shares are currently trading at a 50%-75% discount to recent takeouts in the biotech space, namely Actelion, Ariad and Medivation. He keeps an Outperform rating on Sarepta with a $76 price target. The stock closed yesterday down 10c to $31.40.
06/07/17
SBSH
06/07/17
NO CHANGE
Target $18
SBSH
Buy
PTC Therapeutics shares worth $59 if Translarna is approved, says Citi
Citi analyst Joel Beatty raised his price target for PTC Therapeutics (PTCT) to $18 from $15 and keeps a Buy rating on the shares. The biopharmaceutical company closed yesterday up 76c to $14.31. The analyst increased his probability of approval for Translarna in Duchenne muscular dystrophy to 25% from 20% after the FDA scheduled an advisory panel meeting for September. He believes the shares are worth $59 if Translarna is approved in the U.S. and and $8 if the drug is not approved. The risk/reward is favorable for a U.S. Translarna approval while the Emflaza launch should exceed low Street expectations, Beatty tells investors in a research note. He maintains a Buy rating on PTC. Sarepta Therapeutics' (SRPT) Exondys 51 has already received FDA approval as a treatment for Duchenne muscular dystrophy.

TODAY'S FREE FLY STORIES

HAL

Halliburton

$43.33

-0.09 (-0.21%)

, VFC

VF Corp.

$66.38

1.03 (1.58%)

20:25
10/22/17
10/22
20:25
10/22/17
20:25
Earnings
Notable companies reporting before Monday's open »

Notable companies…

HAL

Halliburton

$43.33

-0.09 (-0.21%)

VFC

VF Corp.

$66.38

1.03 (1.58%)

STT

State Street

$99.12

1.64 (1.68%)

STX

Seagate

$34.94

0.6 (1.75%)

SALT

Scorpio Bulkers

$8.20

0.45 (5.81%)

LOGI

Logitech

$36.71

0.1 (0.27%)

ITW

Illinois Tool Works

$155.03

1.55 (1.01%)

KMB

Kimberly-Clark

$113.44

-2.11 (-1.83%)

HAS

Hasbro

$98.19

1.52 (1.57%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 23

    Oct

  • 24

    Oct

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

, FB

Facebook

$174.98

0.42 (0.24%)

20:10
10/22/17
10/22
20:10
10/22/17
20:10
Hot Stocks
Catch up on the weekend's top five stories with this list compiled by The Fly: »

1. Tesla has reached an…

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

FB

Facebook

$174.98

0.42 (0.24%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

COH

Coach

$40.35

0.88 (2.23%)

DWDP

DowDuPont

$71.18

0.29 (0.41%)

CZR

Caesars

$12.20

0.15 (1.24%)

DAL

Delta Air Lines

$53.27

1 (1.91%)

AAL

American Airlines

$51.93

0.42 (0.82%)

DLAKY

Lufthansa

$30.28

0.2 (0.66%)

SSNLF

Samsung

MS

Morgan Stanley

$50.68

0.89 (1.79%)

UAL

United Continental

$59.90

0.12 (0.20%)

TSLA

Tesla

$345.10

-6.71 (-1.91%)

AET

Aetna

$160.84

3.2 (2.03%)

ANTM

Anthem

$194.69

1.49 (0.77%)

CNC

Centene

$96.50

1.8 (1.90%)

CI

Cigna

$191.42

3.2 (1.70%)

HNT

Health Net

HUM

Humana

$245.81

3.12 (1.29%)

MOH

Molina Healthcare

$64.40

0.76 (1.19%)

UNH

UnitedHealth

$207.49

4.24 (2.09%)

WCG

WellCare

$180.52

3.28 (1.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 24

    Oct

  • 24

    Oct

  • 24

    Oct

  • 25

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 30

    Oct

  • 30

    Oct

  • 31

    Oct

  • 31

    Oct

  • 31

    Oct

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 01

    Nov

  • 02

    Nov

  • 02

    Nov

  • 02

    Nov

  • 03

    Nov

  • 06

    Nov

  • 06

    Nov

  • 08

    Nov

  • 08

    Nov

  • 08

    Nov

  • 09

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

FUL

H.B. Fuller

$57.70

0.63 (1.10%)

20:10
10/22/17
10/22
20:10
10/22/17
20:10
Hot Stocks
H.B. Fuller finalizes acquisition of Royal Adhesives & Sealants »

Boosting H.B.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWX

Time Warner

$101.83

-0.37 (-0.36%)

, CMCSA

Comcast

$37.22

0.32 (0.87%)

18:56
10/22/17
10/22
18:56
10/22/17
18:56
Hot Stocks
Box Office Battle: 'Boo 2' wins weekend with $21.7M »

Lionsgate's (LGF.A)…

TWX

Time Warner

$101.83

-0.37 (-0.36%)

CMCSA

Comcast

$37.22

0.32 (0.87%)

CMCSK

Comcast

SNE

Sony

$37.55

0.11 (0.29%)

FOX

21st Century Fox

$26.84

0.14 (0.52%)

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

LGF.A

Lionsgate

$30.09

-0.08 (-0.27%)

DIS

Disney

$99.40

0.39 (0.39%)

VIAB

Viacom

$26.70

0.17 (0.64%)

VIA

Viacom

$34.00

-0.05 (-0.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 26

    Oct

  • 01

    Nov

  • 08

    Nov

  • 09

    Nov

  • 09

    Nov

  • 16

    Nov

SFNC

Simmons First National

$60.45

0.9 (1.51%)

18:16
10/22/17
10/22
18:16
10/22/17
18:16
Earnings
Simmons First National reports Q3 core EPS 86c, consensus 86c »

Reports Q3 loan loss…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

HLX

Helix Energy

$7.76

-0.13 (-1.65%)

18:09
10/22/17
10/22
18:09
10/22/17
18:09
Earnings
Helix Energy reports Q3 EPS 2c, consensus 2c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

GM

General Motors

$45.61

0.26 (0.57%)

18:00
10/22/17
10/22
18:00
10/22/17
18:00
Periodicals
Driverless-car, emerging tech bets help GM shrug off 'dinosaur' image, WSJ says »

General Motors has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

GOOG

Alphabet

$988.20

3.75 (0.38%)

, GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

17:42
10/22/17
10/22
17:42
10/22/17
17:42
Periodicals
Alphabet turns on internet balloons in Puerto Rico, AP says »

Alphabet's…

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

AAPL

Apple

$156.25

0.27 (0.17%)

, AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

17:30
10/22/17
10/22
17:30
10/22/17
17:30
Periodicals
Facebook, Google spending big money to lobby on Russia, Recode says »

Apple (AAPL), Amazon…

AAPL

Apple

$156.25

0.27 (0.17%)

AMZN

Amazon.com

$982.91

-3.7 (-0.38%)

FB

Facebook

$174.98

0.42 (0.24%)

GOOG

Alphabet

$988.20

3.75 (0.38%)

GOOGL

Alphabet Class A

$1,005.07

3.23 (0.32%)

MSFT

Microsoft

$78.81

0.9 (1.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 24

    Oct

  • 26

    Oct

  • 26

    Oct

  • 26

    Oct

  • 01

    Nov

  • 02

    Nov

  • 08

    Nov

  • 15

    Nov

  • 29

    Nov

  • 18

    Mar

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

, UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

17:26
10/22/17
10/22
17:26
10/22/17
17:26
Conference/Events
Union Bankshares to host special shareholder meeting »

Special Shareholder…

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 15

    Nov

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

, XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

17:23
10/22/17
10/22
17:23
10/22/17
17:23
Conference/Events
Xenith Bankshares to host special shareholder meeting »

Special Shareholder…

UBSH

Union Bankshares

$35.31

-0.21 (-0.59%)

XBKS

Xenith Bankshares

$32.74

-0.1 (-0.30%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    Nov

ROKA

Roka Bioscience

$1.53

-0.24 (-13.56%)

17:20
10/22/17
10/22
17:20
10/22/17
17:20
Conference/Events
Roka Bioscience to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

17:03
10/22/17
10/22
17:03
10/22/17
17:03
Conference/Events
OceanFirst Financial to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Oct

  • 15

    Nov

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

, SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

16:57
10/22/17
10/22
16:57
10/22/17
16:57
Conference/Events
Sun Bancorp to host special shareholder meeting »

Special Shareholder…

OCFC

OceanFirst Financial

$28.01

0.19 (0.68%)

SNBC

Sun Bancorp

$25.60

0.05 (0.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

  • 27

    Oct

  • 15

    Nov

SGU

Star Gas Partners, L.P.

$10.52

-0.16 (-1.50%)

16:49
10/22/17
10/22
16:49
10/22/17
16:49
Conference/Events
Star Gas Partners, L.P. to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

ETRM

EnteroMedics

$2.05

0.07 (3.54%)

16:44
10/22/17
10/22
16:44
10/22/17
16:44
Conference/Events
EnteroMedics to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Oct

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

, SSB

South State

$92.15

-0.2 (-0.22%)

16:39
10/22/17
10/22
16:39
10/22/17
16:39
Conference/Events
South State to host special shareholder meeting »

Special Shareholder…

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

SSB

South State

$92.15

-0.2 (-0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

  • 25

    Oct

  • 25

    Oct

SSB

South State

$92.15

-0.2 (-0.22%)

, PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

16:36
10/22/17
10/22
16:36
10/22/17
16:36
Conference/Events
Park Sterling Bank to host special shareholder meeting »

Special Shareholder…

SSB

South State

$92.15

-0.2 (-0.22%)

PSTB

Park Sterling Bank

$12.84

-0.02 (-0.16%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Oct

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

, CARO

Carolina Financial

$36.17

0.23 (0.64%)

16:22
10/22/17
10/22
16:22
10/22/17
16:22
Conference/Events
Carolina Financial to host special shareholder meeting »

Special Shareholder…

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

CARO

Carolina Financial

$36.17

0.23 (0.64%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

CARO

Carolina Financial

$36.17

0.23 (0.64%)

, FSBK

First South Bancorp

$18.66

0.14 (0.76%)

16:19
10/22/17
10/22
16:19
10/22/17
16:19
Conference/Events
First South Bancorp to host special shareholder meeting »

Special Shareholder…

CARO

Carolina Financial

$36.17

0.23 (0.64%)

FSBK

First South Bancorp

$18.66

0.14 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Oct

FOXA

21st Century Fox

$27.50

0.13 (0.47%)

13:41
10/22/17
10/22
13:41
10/22/17
13:41
Periodicals
Fox knew of new harassment settlement before signing O'Reilly, Reuters says »

Forced to resign in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

TM

Toyota

$123.71

0.64 (0.52%)

13:37
10/22/17
10/22
13:37
10/22/17
13:37
Periodicals
Toyota to halt operations at Japan plants as typhoon approaches, Reuters says »

Toyota is suspending…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

, BAC

Bank of America

$27.17

0.59 (2.22%)

13:34
10/22/17
10/22
13:34
10/22/17
13:34
Hot Stocks
IntercontinentalExchange completes BofA Merrill's Index Platform acquisition »

Intercontinental Exchange…

ICE

IntercontinentalExchange

$66.12

-0.73 (-1.09%)

BAC

Bank of America

$27.17

0.59 (2.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

  • 23

    Oct

  • 02

    Nov

VCYT

Veracyte

$9.30

0.11 (1.20%)

13:30
10/22/17
10/22
13:30
10/22/17
13:30
Hot Stocks
Veracyte announces new data, highlights Afirma GSC performance »

Veracyte announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRK

Merck

$63.88

0.13 (0.20%)

13:19
10/22/17
10/22
13:19
10/22/17
13:19
Hot Stocks
Study shows Merck Zepatier resulted in high sustained virologic response rates »

Merck has announced the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

  • 27

    Oct

  • 06

    Nov

  • 08

    Nov

  • 16

    Nov

  • 30

    Nov

  • 02

    Feb

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.